McCrimmon, Rory J.
Henry, Robert R.
Funding for this research was provided by:
University of Dundee
Article History
Received: 26 March 2018
Accepted: 23 May 2018
First Online: 22 August 2018
Duality of interest
: RJM has received honoraria for educational talks and advisory activity from Sanofi, Novo Nordisk and Eli Lilly. RRH has received research funding from Abbott, AstaMed, Eli Lilly, Hitachi, Novo Nordisk, Sanofi-Lexicon and Viacyte and has been a consultant/advisory panel member for Abbott, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Elcelyx, Intarcia, Ionis, Janssen/Johnson & Johnson, Ligand, Merck, Regerneron and Sanofi-Aventis.